FDA Clarifies Approach to Genomic Alterations in Animals
May 7, 2024 —
Today, the U.S. Food and Drug Administration took important steps to advance the FDA's regulatory process for intentional genomic alterations (IGAs) in animals. The updated guidance documents underscore the agency's commitment to further modernize its approach to evaluating and supporting the development of innovative animal and veterinary products to increase regulatory flexibility, predictability and efficiency. In addition, the agency established a memorandum of understanding (MOU) with the U.S. Department of Agriculture (USDA) to clarify roles and responsibilities for regulation of IGAs in animals.
Read the announcement at FDA.
[Source: FDA 1 May 2024]
- Next story: FDA Finalizes Guidance to Provide Further Clarity on Veterinary Feed Directives
- Previous in category: Senate, House Ag Committees Issue Farm Bill Frameworks
- Previous story: Senate, House Ag Committees Issue Farm Bill Frameworks